Sydney - Friday - August 1: (RWE Australian Business News) -
HeartWare (ASX: HTW) says the Institutional Review Board of Washington
Hospital Center has approved centre's participation in the clinical
trial of the HeartWare Left Ventricular Assist System.
It is the first US centre to approve the study.
- Forums
- ASX - By Stock
- HTW
- may be of value
HTW
heartware limited
may be of value
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)